Cristcot Appoints Jenny Gizzi as Chief Administrative Officer
Biopharma Operations Leader Brings Proven Track Record in Organizational Strategy, Talent, and Growth Enablement CONCORD, Mass., May 19, 2025 /PRNewswire/ —... Read more.
Cellula Robotics Partners with Subsea Europe Services and FLANQ to Expand AUV Market Reach in Northern Europe
BURNABY, BC and ROSTOCK, Germany, May 19, 2025 /PRNewswire/ – Cellula Robotics Limited has entered into a sales and representation agreement with Subsea Europe... Read more.
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS
Investor call and webcast scheduled for today at 8:30 a.m. ET NEW YORK, May 19, 2025 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading... Read more.
Leading Rapid Manufacturer Launches Marketplace, Empowering Entrepreneurs to Monetize Designs
RENO, Nev., May 19, 2025 /PRNewswire/ — U.S.-based custom sheet metal manufacturer, SendCutSend, announced the launch of the SendCutSend Marketplace, an online... Read more.
CoreWeave Announces Intention to Offer $1,500 million of Senior Notes
LIVINGSTON, N.J., May 19, 2025 /PRNewswire/ — CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) announced today that it intends, subject to market... Read more.
Compugen Reports First Quarter 2025 Results
Initiated platform trial of COM701 maintenance therapy in patients with platinum sensitive ovarian cancer in Q2 2025 Recruitment ongoing in the first in human Phase... Read more.
MAGRABi RETAIL GROUP ACQUIRING LEADING KUWAITI RETAILER, KEFAN OPTICS
The Middle East’s leading eyewear retailer continues M&A expansion into 2025 Once completed, this acquisition will significantly expand the existing footprint... Read more.
Smartkem Collaborates with Manz Asia for Advanced Computer and AI Chip Packaging Solutions
Manz Asia will be demonstrating its advanced inkjet metallization using Smartkem’s advanced dielectric materials at SEMICON® SEA 2025 in Singapore, May 20-22,... Read more.
Armata Pharmaceuticals Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia
All primary endpoints for safety, tolerability, and clinical response in the intent-to-treat population met AP-SA02 arm significantly improved clinical outcomes... Read more.
Infosys a Top 100 Global Brand for 2025. Achieves 34% Brand Value Surge, Ranks among the Top 5% of Most Trusted Brands in the U.S.
BENGALURU, India, May 19, 2025 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting,... Read more.